78285532 - RHUDEX

Information

  • Trademark
  • 78285532
  • Serial Number
    78285532
  • Registration Number
    2943640
  • Filing Date
    August 11, 2003
    21 years ago
  • Registration Date
    April 26, 2005
    19 years ago
  • Transaction Date
    November 06, 2012
    12 years ago
  • Status Date
    September 28, 2012
    12 years ago
  • Published for Opposition Date
    February 01, 2005
    19 years ago
  • Location Date
    April 26, 2005
    19 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SUAREZ, MARIA VICTORIA
  • Attorney Docket Number
    21573.Avidex
    Attorney Name
    Purvi J. Patel
    Law Office Assigned Location Code
    L20
  • Owners
Mark Drawing Code
1000
Mark Identification
RHUDEX
Case File Statements
  • GS0051: Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics
  • GS0101: Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors, syringes, pre-filled vials containing pharmaceuticals and bioceuticals, namely small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases
  • GS0421: Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property namely, trademarks and patents in the field of biotechnology
Case File Event Statements
  • 9/28/2012 - 12 years ago
    16 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 12/17/2008 - 16 years ago
    15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/17/2008 - 16 years ago
    14 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/19/2007 - 17 years ago
    13 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 4/26/2005 - 19 years ago
    12 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/1/2005 - 19 years ago
    11 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/12/2005 - 20 years ago
    10 - NOTICE OF PUBLICATION Type: NPUB
  • 11/30/2004 - 20 years ago
    9 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 11/29/2004 - 20 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 11/21/2004 - 20 years ago
    7 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/30/2004 - 20 years ago
    6 - AMENDMENT FROM APPLICANT ENTERED Type: ACEC
  • 8/5/2004 - 20 years ago
    5 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/5/2004 - 20 years ago
    4 - Sec. 1(B) CLAIM DELETED Type: 1.BD
  • 8/5/2004 - 20 years ago
    3 - PAPER RECEIVED Type: MAIL
  • 2/3/2004 - 20 years ago
    2 - NON-FINAL ACTION MAILED Type: CNRT
  • 1/24/2004 - 21 years ago
    1 - ASSIGNED TO EXAMINER Type: DOCK